ALKS Q3 2022 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$252M-14.2% YoY

Gross Profit

$202M79.9% margin

Operating Income

-$61M-24.0% margin

Net Income

-$64M-25.4% margin

EPS (Diluted)

$-0.39

QoQ Revenue Growth

-8.6%

Cash Flow

Operating Cash Flow

$625,000

Free Cash Flow

-$10M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$899M

Stockholders' Equity

$1.0B

Cash & Equivalents

$264M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$252M	$294M	-14.2%
Gross Profit	$202M	$245M	-17.5%
Operating Income	-$61M	-$20M	-208.5%
Net Income	-$64M	-$29M	-120.7%

Revenue Segments

Manufacturing Revenue

$17M100%